{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:51:57Z","timestamp":1784317917045,"version":"3.55.0"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug Development Research"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The causative agent of coronavirus disease\u20102019 (COVID\u201019), severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102), enters the host cells via an angiotensin\u2010converting enzyme 2 (ACE2)\u2010mediated endocytosis\u2010dependent manner. Because ACE2 is highly expressed in the heart, SARS\u2010CoV\u20102 can severely infect heart tissue and arteries, causing acute and chronic damage to the cardiovascular system. Therefore, special attention should be paid to finding appropriate agents to protect this vital system during COVID\u201019 treatment. Papaverine is a unique vasodilator alkaloid that is clinically used in the treatment of vasospasm. Interestingly, this compound has potent and direct effects on a wide range of viruses, and could also prevent viral exploitation mechanisms of the host cell facilities by inhibiting some cellular signaling pathways such as p38 MAPK. This pathway was recently introduced as a promising target for the treatment of COVID\u201019. Papaverine also has anti\u2010inflammatory effects which is useful in combating the hyper\u2010inflammatory phase of the COVID\u201019. Unlike some medications that have severe dosage\u2010restrictions in the treatment of COVID\u201019 due to cardiac side effects, papaverine is recommended for use in many heart disorders. The ability of papaverine to treat COVID\u201019 has become more promising when the results of some extensive screenings showed the strong ability of this compound to inhibit the cytopathic effects of SARS\u2010CoV\u20102 with EC<jats:sub>50<\/jats:sub> of 1.1\u2009\u03bcM. Having several therapeutic effects along with desired safety profile raises this hypothesis that papaverine could be a promising compound for the suppression of SARS\u2010CoV\u20102 and prevention of ischemia\/vasoconstriction\u2010related complications in COVID\u201019 disease, especially in patients with underlying cardiovascular diseases (CVDs).<\/jats:p>","DOI":"10.1002\/ddr.21961","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T01:44:41Z","timestamp":1655343881000},"page":"1246-1250","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Papaverine, a promising therapeutic agent for the treatment of COVID\u201019 patients with underlying cardiovascular diseases (CVDs)"],"prefix":"10.1002","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6689-3743","authenticated-orcid":false,"given":"Mehdi","family":"Valipour","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy Mazandaran University of Medical Sciences Sari Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7513-6162","authenticated-orcid":false,"given":"Hamid","family":"Irannejad","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy Mazandaran University of Medical Sciences Sari Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-6621","authenticated-orcid":false,"given":"Saeed","family":"Emami","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy Mazandaran University of Medical Sciences Sari Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01888-19"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0720-y"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.20114"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6858.870"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.04.006"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-021-00848-4"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.01.059"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-014-0063-6"},{"key":"e_1_2_4_10_1","first-page":"935","article-title":"Kinase inhibitors as underexplored antiviral agents","volume":"27","author":"Garc\u00eda\u2010C\u00e1rceles J.","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2020.05.007"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2020.07.008"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21656"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21689"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa106"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2020.03.229"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.09.006"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.2.785-793.2006"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00804-10"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0413-9"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2009.02153.x"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000256831.33459.ea"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf7872"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21666"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102755"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00023-19"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2020.10.005"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12159"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21709"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1871"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd6030027"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2021.1982509"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17071037"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.73.3.444"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13993-7"}],"container-title":["Drug Development Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.21961","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ddr.21961","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.21961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:48:36Z","timestamp":1760377716000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/ddr.21961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1002\/ddr.21961"],"URL":"https:\/\/doi.org\/10.1002\/ddr.21961","archive":["Portico"],"relation":{},"ISSN":["0272-4391","1098-2299"],"issn-type":[{"value":"0272-4391","type":"print"},{"value":"1098-2299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"2022-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}